Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingjiang Hu

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|March 16, 2021
ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver MetastasisRyota Nakanishi, Eiji Oki, Hirofumi Hasuda, et al.
Annals of Surgical Oncology|January 17, 2021
Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based ChemotherapyRyota Nakanishi, Eiji Oki, Hirofumi Hasuda, et al.
Anticancer Research|May 7, 2017
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal CancerKuniaki Sato, Takaaki Masuda, Qingjiang Hu, et al.
Plos One|November 9, 2016
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver MetastasisTomohiro Iguchi, Sho Nambara, Takaaki Masuda, et al.
Annals of Surgical Oncology|October 23, 2016
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular CarcinomaHisateru Komatsu, Tomohiro Iguchi, Takaaki Masuda, et al.
Oncology|June 18, 2018
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell CarcinomaTomohiro Iguchi, Masami Ueda, Takaaki Masuda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 20, 2026
Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab responseYuho Ebata, Eiji Oki, Qingjiang Hu, et al.
Cancer Genomics & Proteomics|February 29, 2020
KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular CarcinomaAkihiro Kitagawa, Takaaki Masuda, Junichi Takahashi, et al.
Anticancer Research|December 6, 2015
Clinical Significance of Expression of Nephroblastoma Overexpressed (NOV) in Patients with Colorectal CancerMasami Ueda, Tomohiro Iguchi, Hisateru Komatsu, et al.
Journal of Gastroenterology|April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinomaTomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|March 16, 2021
ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver MetastasisRyota Nakanishi, Eiji Oki, Hirofumi Hasuda, et al.
Annals of Surgical Oncology|January 17, 2021
Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based ChemotherapyRyota Nakanishi, Eiji Oki, Hirofumi Hasuda, et al.
Anticancer Research|May 7, 2017
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal CancerKuniaki Sato, Takaaki Masuda, Qingjiang Hu, et al.
Plos One|November 9, 2016
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver MetastasisTomohiro Iguchi, Sho Nambara, Takaaki Masuda, et al.
Annals of Surgical Oncology|October 23, 2016
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular CarcinomaHisateru Komatsu, Tomohiro Iguchi, Takaaki Masuda, et al.
Oncology|June 18, 2018
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell CarcinomaTomohiro Iguchi, Masami Ueda, Takaaki Masuda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 20, 2026
Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab responseYuho Ebata, Eiji Oki, Qingjiang Hu, et al.
Cancer Genomics & Proteomics|February 29, 2020
KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular CarcinomaAkihiro Kitagawa, Takaaki Masuda, Junichi Takahashi, et al.
Anticancer Research|December 6, 2015
Clinical Significance of Expression of Nephroblastoma Overexpressed (NOV) in Patients with Colorectal CancerMasami Ueda, Tomohiro Iguchi, Hisateru Komatsu, et al.
Journal of Gastroenterology|April 20, 2026
Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinomaTomohiko Ikehara, Hajime Otsu, Taro Tobo, et al.
Pageof 10